Abstract:Type 1 diabetes mellitus (T1DM) arises from insulin deficiency resulting from the destruction of pancreatic β‐cells. Treatment usually entails daily insulin injections, but challenges endure. Allogeneic pancreatic islet transplantation holds promise, yet its viability is constrained by organ scarcity. Xenotransplantation of porcine islets provides an alternative, impeded by immune rejection. Strategies such as genetic modification and immunoisolation aim to improve graft survival, explored in this review (created with Biorender.com). Type 1 diabetes mellitus (T1DM) is characterized by absolute insulin deficiency primarily due to autoimmune destruction of pancreatic β‐cells. The prevailing treatment for T1DM involves daily subcutaneous insulin injections, but a substantial proportion of patients face challenges such as severe hypoglycemic episodes and poorly controlled hyperglycemia. For T1DM patients, a more effective therapeutic option involves the replacement of β‐cells through allogeneic transplantation of either the entire pancreas or isolated pancreatic islets. Unfortunately, the scarcity of transplantable human organs has led to a growing list of patients waiting for an islet transplant. One potential alternative is xenotransplantation of porcine pancreatic islets. However, due to inter‐species molecular incompatibilities, porcine tissues trigger a robust immune response in humans, leading to xenograft rejection. Several promising strategies aim to overcome this challenge and enhance the long‐term survival and functionality of xenogeneic islet grafts. These strategies include the use of islets derived from genetically modified pigs, immunoisolation of islets by encapsulation in biocompatible materials, and the creation of an immunomodulatory microenvironment by co‐transplanting islets with accessory cells or utilizing immunomodulatory biomaterials. This review concentrates on delineating the primary obstacles in islet xenotransplantation and elucidates the fundamental principles and recent breakthroughs aimed at addressing these challenges.

Construction of EMSC-islet co-localizing composites for xenogeneic porcine islet transplantation

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes

Construction of engineered 3D islet micro-tissue using porcine decellularized ECM for the treatment of diabetes

Co-transplantation of human adipose-derived mesenchymal stem cells with neonatal porcine islets within a prevascularized subcutaneous space augments the xenograft function

Engineering of Hybrid Spheroids of Mesenchymal Stem Cells and Drug Depots for Immunomodulating Effect in Islet Xenotransplantation

A bilaminated decellularized scaffold for islet transplantation: Structure, properties and functions in diabetic mice

Microencapsulated Pig Islet Xenotransplantation As an Alternative Treatment of Diabetes.

Immunoprotection Strategies in β‐Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation

The Reversal of Hyperglycaemia in Diabetic Mice Using Plga Scaffolds Seeded with Islet-Like Cells Derived from Human Embryonic Stem Cells

Co-transplantation of Islets-Laden Microgels and Biodegradable O2-Generating Microspheres for Diabetes Treatment

Construction of PLGA Porous Microsphere-Based Artificial Pancreatic Islets Assisted by the Cell Centrifugation Perfusion Technique

Recent progress in porcine islet isolation, culture and engraftment strategies for xenotransplantation

Porcine embryonic stem cells: An alternative solution for the shortage of human islets to treat type 1 diabetes?

A COLLAGEN-CHITOSAN SCAFFOLD AS A POSSIBLE HIGHLY VASCULARIZED ECTOPIC SITE FOR PANCREATIC ISLET TRANSPLANTATION

Microencapsulation in Clinical Islet Xenotransplantation

THE POTENTIAL OF HYBRID PORCINE ISLET XENOGRAFT IN THE THERAPY OF TYPE I DIABETES

High-Efficiency, Prevascularization-Free Macroencapsulation System for Subcutaneous Transplantation of Pancreatic Islets for Enhanced Diabetes Treatment

Generating low immunogenic pig pancreatic islet cell clusters for xenotransplantation

Interpenetrating Network of Alginate–Human Adipose Extracellular Matrix Hydrogel for Islet Cells Encapsulation

Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: preliminary results